36 Results for "

Centrosome

" in MedChemExpress (MCE) Product Catalog:
Products (36)

36 Results for "Centrosome" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-145967
CAS No.: 2413991-74-7
Purity:  98.03%
Target:  

Deubiquitinase Mitosis

Research Areas:  

Cancer

FT709 is a potent and selective USP9X inhibitor, an IC50 of 82 nM. USP9X has been linked with centrosome function, chromosome alignment during mitosis, EGF receptor degradation, chemo-sensitization, and circadian rhythms .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W286743
CAS No.: 5746-04-3
Synonyms: CML; N6-(Carboxymethyl)-L-lysine; Nε-(1-Carboxymethyl)-L-lysine
Nε-(Carboxymethyl)-L-lysine (CML) is an orally active advanced glycation end product. Nε-(Carboxymethyl)-L-lysine upregulates the expression of PLK1 and CEP20, and induces the activation of RAGE and ERK/NFκB. Nε-(Carboxymethyl)-L-lysine drives centrosome amplification. Nε-(Carboxymethyl)-L-lysine induces malignant transformation of hepatocytes and promotes the development of hepatocellular carcinoma. Nε-(Carboxymethyl)-L-lysine induces epithelial-mesenchymal transition in osteosarcoma cells and enhances their migration and invasion properties .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-114302
CAS No.: 2100864-57-9
Purity:  99.89%
Target:  

Microtubule/Tubulin

Research Areas:  

Cancer

CCB02 is a selective CPAP-tubulin interaction inhibitor, binding to tubulin and competing for the CPAP binding site of β-tubulin, with an IC50 of 689 nM, and shows potent anti-tumor activity. CCB02 shows no inhibition on the cell cycle- and centrosome-related kinases, or the phosphorylation status of Aurora A, Plk1, Plk2, CDK2, and CHK1 .
loading...
    loading...
Cat. No.: HY-138084
CAS No.: 2410846-16-9
Purity:  99.83%
Target:  

Separase Mitosis

Research Areas:  

Cancer

SIC5-6 is a potent Separase inhibitor. Separase, a large cysteine protease, involves in chromosome segregation during mitosis and meiosis, DNA damage repair, centrosome disengagement and duplication, spindle stabilization and elongation. Separase is highly overexpressed in many solid cancers, serves as an attractive chemotherapeutic target .
loading...
    loading...
Cat. No.: HY-W199190
CAS No.: 693-07-2
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

2-CEES is a mustard gas analog forms only DNA monoadducts. 2-CEES induces centrosome amplification in human and mouse cells. 2-CEES induces centrosome amplification and chromosome instability .
loading...
    loading...
Cat. No.: HY-149075
CAS No.: 3027761-24-3
Research Areas:  

Cancer

MR22 is a potent pan-SIK (salt-inducible kinase) inhibitor. MR22 no longer exhibits activity on STE group kinases and displays excellent selectivity in a representative kinase panel. MR22-dependent SIK inhibition led to centrosome dissociation and subsequent cell-cycle arrest in ovarian cancer cells .
loading...
    loading...
Cat. No.: HY-P11118A
Synonyms: CAPture peptide, biotin-CCDC61 (334-366) TFA
Research Areas:  

Others

Biotinylated CCDC61 peptide (CAPture peptide, biotin-CCDC61 (334-366)) TFA is a biotinylated peptide derived from the centrosomal protein CCDC61. Biotinylated CCDC61 peptide TFA specifically isolates intact centrosomes .
loading...
    loading...
Cat. No.: HY-149085
CAS No.: 346721-50-4
Purity:  98.67%
Target:  

RAR/RXR

Research Areas:  

Cancer

XS-060 is a potent anticancer agent and RXRα antagonist. XS-060 significantly induces RXRα-dependent mitotic arrest by inhibiting pRXRα-PLK1 interaction. XS-060 inhibits p-RXRα interaction with PLK1 but has no effect on RXRα heterodimerization with RARγ. XS-060 inhibits the in situ interaction between p-RXRα and PLK1 at the centrosome .
loading...
    loading...
Cat. No.: HY-N11128
CAS No.: 19941-91-4
Solidagonic acid is an acidic bitter principle that can be found in the root and rhizomes of Solidago altissima L. Solidagonic acid binds HSET/KIFC1, restores growth in HSET-overproducing fission yeast cells and reverts mitotic spindles from monopolar to bipolar morphology. Solidagonic acid can be used for the research of breast adenocarcinoma .
loading...
    loading...
Cat. No.: HY-120284
CAS No.: 215778-97-5
Purity:  99.76%
Target:  

Microtubule/Tubulin

Research Areas:  

Cancer

CCCI-01 is a centrosome clustering inhibitor. CCCI-01 has selective effects on cancer. CCCI-01 can be used for the research of non-cross-resistant anti-cancer agents with blocking centrosome clustering .
loading...
    loading...
Cat. No.: HY-100847
CAS No.: 1825345-52-5
Target:  

PARP

Research Areas:  

Cancer

AZ0108 is an inhibitor for poly ADP-ribose polymerase (PARP), which inhibits PARP1, PARP2, PARP3, PARP6, TNKS1, TNKS2, with IC50s of <0.03, <0.03, 2.8, 0.083, 3.2, >3 μM, respectively. AZ0108 prevents centrosome clustering with an EC50 of 0.053 μM, and exhibits cytotoxicity in cell OCI-LY-19 with GI50 of 0.017 μM. AZ0108 exhibits good in vivo pharmacokinetic characters in rat/mouse models .
loading...
    loading...
Cat. No.: HY-146146
CAS No.: 2379777-37-2
Synonyms: KAA
Target:  

Kinesin

Research Areas:  

Cancer

Kolavenic acid analog (KAA) is an anticancer agent. Kolavenic acid analog shows strong activity against HSET-overproducing yeast cells. Kolavenic acid analog inhibits centrosome clustering in human cancer cells containing high HSET levels and supernumerary centrosomes .
loading...
    loading...
Cat. No.: HY-P11118
Synonyms: CAPture peptide, biotin-CCDC61 (334-366)
Research Areas:  

Others

Biotinylated CCDC61 peptide (CAPture peptide, biotin-CCDC61 (334-366)) is a biotinylated peptide derived from the centrosomal protein CCDC61. Biotinylated CCDC61 peptide specifically isolates intact centrosomes .
loading...
    loading...
Cat. No.: HY-124519
CAS No.: 331749-88-3
Synonyms: Cent-1
Target:  

Microtubule/Tubulin

Research Areas:  

Cancer

Centmitor-1 (Cent-1) is a mitotic arrest inducer. Centmitor-1 modulates microtubule plus-ends and reduced microtubule dynamics. In cells, Centmitor-1 causes mitotic arrest characterized by chromosome alignment defects, multipolar spindles, centrosome fragmentation, and activated spindle assembly checkpoint .
loading...
    loading...
Cat. No.: HY-174563
Target:  

mRNA

Research Areas:  

Cancer

Human OLA1 mRNA encodes the human Obg like ATPase 1 (OLA1) protein, a member of the GTPase protein family. OLA1 interacts with breast cancer-associated gene 1 (BRCA1) and BRCA1-associated RING domain protein (BARD1), and is involved in centrosome regulation.
loading...
    loading...
Cat. No.: HY-P86826
Synonyms: Centrosome and spindle pole-associated protein 1 CSPP1 CSPP

Host:  

Rabbit

Application:  

WB

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-186208
CAS No.: 3115244-67-9
Target:  

Aurora Kinase

Research Areas:  

Cancer

TACC3-IN-3 is a TACC3 inhibitor. TACC3 is a scaffold protein that is highly expressed in various tumors and regulates microtubule/centrosome stability via phosphorylation by Aurora A. TACC3-IN-3 inhibits the proliferation of triple-negative breast cancer cells. TACC3-IN-3 is applicable to triple-negative breast cancer research .\n
loading...
    loading...
Cat. No.: HY-186209
CAS No.: 3115244-17-9
Target:  

Aurora Kinase

Research Areas:  

Cancer

TACC3-IN-4 is a TACC3 inhibitor. TACC3 is a scaffold protein that is highly expressed in various tumors and regulates microtubule/centrosome stability via phosphorylation by Aurora A. TACC3-IN-4 inhibits the proliferation of triple-negative breast cancer cells. TACC3-IN-4 can be used for triple-negative breast cancer research .
loading...
    loading...
Cat. No.: HY-186210
CAS No.: 3115244-37-3
Target:  

Aurora Kinase

Research Areas:  

Cancer

TACC3-IN-5 (Compound 35) is a TACC3 inhibitor. TACC3 is a scaffold protein that is highly expressed in various tumors and regulates microtubule/centrosome stability via phosphorylation by Aurora A. TACC3-IN-5 inhibits the proliferation of triple-negative breast cancer cells. TACC3-IN-5 is applicable for triple-negative breast cancer research .
loading...
    loading...
Cat. No.: HY-104023
CAS No.: 891849-87-9
Research Areas:  

Cancer

ZK-Thiazolidinone is an ATP-competitive Polo-like kinase 1 (Plk1) inhibitor with an IC50 of 19 nM. ZK-Thiazolidinone inhibits tumor cell proliferation, induces cell cycle arrest and typical mitotic defects. ZK-Thiazolidinone impairs the recruitment of γ-tubulin and Aurora A kinase to centrosomes, resulting in failure of bipolar spindle maintenance and sister chromatid arm cohesion.\nZK-Thiazolidinone is applicable for cancer research .
loading...
    loading...